Global Radiation Oncology Market Trends and Drivers, Restraints, and Opportunities 2018-2024

  • Product Code:
    RP-ID-10082620
  • Published Date:
    Apr 2019
  • Region:
    Global
  • Pages:
    103
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Infoholic Research
Global Radiation Oncology Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018–2024
Overview: Radiation oncology is a medical specialty that uses high energy radiation such as gamma rays, X-rays, protons, or electrons for cancer treatment. These high energy ionizing radiation damage nucleic acids, either directly or indirectly, through the formation of reactive oxygen species and free radicals. Radiation treatment can be used in combination with chemotherapy, surgery, and immunotherapy. According to the estimation of National Cancer Institute, in the US, around 1.6 million new cases of cancer are diagnosed, and 595,690 people have died due to cancer in 2016. According to the study of World Health Organization, approximately 14 million new cancer cases were diagnosed and is expected to increase by about 70% over the next 2 decades. Increasing cancer cases and increasing adoption of non-invasive procedures in emerging countries are expected to fuel the growth of the radiation oncology market in the near future.
The radiation oncology market is booming due to increasing incidences of cancer globally, increasing elderly population, and technological advancements. The high cost of instrument and therapy, side effects, and lack of trained technicians in developing countries are few of the factors hampering the market growth. The markets in emerging countries are expected to grow rapidly during the forecast period due to increasing healthcare spending, growing patient pool, and increasing healthcare awareness among the public.
Market Analysis: The “Global Radiation Oncology” market is estimated to witness a CAGR of 6.7% during the forecast period 2018–2024. The market is analyzed based on four segments – therapy type, application, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is set to be the leading region for the radiation oncology market growth followed by Europe, Asia Pacific, and Rest of the World.
Therapy Type Analysis: The market, by therapy type, is segmented into external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. External beam radiation therapy occupied the largest share in 2017 due to its high usability, and it is a highly effective treatment for various cancer types such as prostate cancer (that can cure up to 95% of cases). External beam radiation therapy is further segmented by technology and products. The technologies include IGRT, IMRT, VMAT, SBRT, SRS, IMPT, and others. Various products include linear accelerators and proton therapy systems among others.
Application Analysis: The market, by application, is segmented into prostate cancer, cervical cancer, breast cancer, lung cancer, head & neck cancer, brain cancer, and others. Prostate cancer occupies the largest market share and is expected to be the fastest growing segment during the forecast period.
End-users Analysis: The market, by end-users, is segmented into hospitals, radiation therapy centers, ambulatory service centers, and others. Hospitals occupied a significant share of the radiation oncology market in 2016, and this trend is expected to continue for the next 5 years.
Key Players: Accuray Incorporated, Elekta AB, Varian Medical Systems, C.R. Bard, Inc., IBA Worldwide, Carl Zeiss Meditec AG, Mevion Medical Systems, Nordion, Inc., IsoRay, Inc., Hitachi Medical Corporation, ViewRay, Inc., and other predominate & niche players.
Competitive Analysis: Currently, external beam radiation therapy dominates the global radiation oncology market. The existing leading players and other predominant market players are concentrating on this market to offer advanced and innovative products with fewer side effects. The key market players are acquiring small companies to enhance their product portfolio and strengthen their leadership position in the market. Apart from this, major players are launching new radiation therapy products to have the edge in the market. For instance, in May 2017, Varian Medical Systems introduced the Halcyon system, an entirely new device for cancer treatment. In September 2017, Qfix launched new radiotherapy positioning technology for the accurate treatment of breast cancer.
Benefits: The report provides complete details about the usage and adoption rate of radiation oncology products in various applications and regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives toward the product adoption in the upcoming years along with the details of commercial products available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:


Table of Contents
1 INDUSTRY OUTLOOK 9
1.1 Industry overview 9
1.2 Industry Trends 9
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 11
2.3 Research Methodology 11
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Market Definition – Infoholic Research 13
3.2 Advantages of Radiation Oncology 13
3.3 Side-effects of Radiation Oncology 13
3.4 Segmented Addressable Market (SAM) 13
3.5 Trends of the Radiation Oncology market 14
3.6 Related Markets 15
3.6.1 Cancer immunotherapy 15
3.6.2 Oncology drugs 16
4 Market Outlook 16
4.1 Overview 16
4.2 Funding scenario 17
4.3 Market segmentation 17
4.4 PEST Analysis 18
4.5 Porter 5(Five) Forces 20
5 Market Characteristics 21
5.1 DRO – Global Radiation Oncology Market Dynamics 21
5.1.1 Drivers 21
5.1.1.1 Growing incidence of cancer globally 21
5.1.1.2 Advancement in technology 22
5.1.2 Opportunities 22
5.1.2.1 Growing elderly population 22
5.1.2.2 Increasing adoption of non-invasive procedures in emerging countries 23
5.1.3 Restraints 24
5.1.3.1 Lack of trained technicians in developing countries 24
5.1.3.2 Side effects 24
5.1.3.3 High cost of instrument and therapy 24
6 Therapy type: Market Size and Analysis 27
6.1 Overview 27
6.2 External beam radiation therapy (EBRT) 29
6.2.1 By technology 29
6.2.1.1 Image-guided radiation therapy (IGRT) 30
6.2.1.2 Intensity-modulated radiation therapy (IMRT) 31
6.2.1.3 Volumetric modulated arc therapy (VMAT) 31
6.2.1.4 Stereotactic body radiation therapy (SBRT) 32
6.2.1.5 Intensity modulated proton therapy (IMPT) 32
6.2.1.6 Stereotactic radiosurgery (SRS) 33
6.2.1.7 Others 33
6.2.2 By Products 34
6.2.2.1 Linear accelerator (LINAC) 35
6.2.2.2 Proton therapy systems 35
6.3 Internal beam radiation therapy/Brachytherapy 36
6.3.1 By technology 37
6.3.1.1 High Dose Rate (HDR) brachytherapy 38
6.3.1.2 Low Dose Rate (LDR) brachytherapy 38
6.3.1.3 Others 38
6.3.2 By Products 39
6.3.2.1 Seeds 40
6.3.2.2 Applicators, afterloaders and other accessories 40
6.4 Systemic beam radiation therapy 41
7 Application: Market Size and Analysis 43
7.1 Overview 43
7.2 Prostate cancer 44
7.3 Cervical cancer 44
7.4 Breast cancer 45
7.5 Lung cancer 46
7.6 Head and Neck cancer 47
7.7 Brain cancer 47
7.8 Others 48
8 End Users: Market Size and Analysis 48
8.1 Overview 48
8.2 Hospitals 49
8.3 Radiation therapy centres 50
8.4 Ambulatory surgery centers 50
8.5 Others 50
9 Regions: Market Size and Analysis 51
9.1 Overview 51
9.2 North America 52
9.2.1 Overview 52
9.2.2 US 53
9.2.3 Canada 54
9.3 Europe 54
9.3.1 Overview 54
9.3.2 UK 55
9.3.3 Germany 56
9.3.4 France 56
9.3.5 Spain 56
9.4 APAC 57
9.4.1 Overview 57
9.4.2 India 57
9.4.3 China 58
9.4.4 Japan 59
9.5 Rest of the World 59
9.5.1 Overview 59
9.5.2 Brazil 60
9.5.3 Middle East 60
10 Competitive Landscape 61
10.1 Overview 61
11 Vendor Profiles 65
11.1 Accuray Incorporated 65
11.1.1 Overview 65
11.1.2 Geographic Presence 68
11.1.3 Business Focus 68
11.1.4 SWOT Analysis 69
11.1.5 Business Strategies 69
11.2 Elekta 70
11.2.1 Overview 70
11.2.2 Geographic Presence 73
11.2.3 Business Focus 73
11.2.4 SWOT Analysis 74
11.2.5 Business Strategy 74
11.3 Varian Medical Systems 75
11.3.1 Overview 75
11.3.2 Business Units 77
11.3.3 Geographic Presence 78
11.3.4 Business Focus 79
11.3.5 SWOT Analysis 79
11.3.6 Business Strategies 80
11.4 C. R. Bard, Inc. 81
11.4.1 Overview 81
11.4.2 Business Units 83
11.4.3 Business Focus 85
11.4.4 SWOT Analysis 85
11.4.5 Business Strategies 85
11.5 IBA worldwide 86
11.5.1 Overview 86
11.5.2 Business Units 88
11.5.3 Geographic Presence 89
11.5.4 Business Focus 90
11.5.5 SWOT Analysis 90
11.5.6 Business Strategies 91
12 Companies to Watch For 92
12.1 CARL ZEISS MEDITEC AG 92
12.1.1 Overview 92
12.1.2 Carl Zeiss Meditec AG: Recent Developments 93
12.2 Mevion Medical Systems 93
12.2.1 Overview 93
12.2.2 Mevion Medical Systems, Inc.: Recent Developments 93
12.3 Nordion, Inc. 94
12.3.1 Overview 94
12.3.2 Nordion, Inc.: Recent Developments 95
12.4 IsoRay, Inc. 96
12.4.1 Overview 96
12.4.2 IsoRay, Inc.: Recent Developments 97
12.5 Hitachi Medical Corporation 97
12.5.1 Overview 97
12.5.2 Hitachi Medical Corporation: Recent Developments 97
12.6 ViewRay, Inc. 98
12.6.1 Overview 98
12.6.2 ViewRay, Inc.: Recent Developments 99
13 Annexure 99
13.1 Abbreviations 99

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Accuray Incorporated, Elekta AB, Varian Medical Systems, C.R. Bard, Inc., IBA Worldwide, Carl Zeiss Meditec AG, Mevion Medical Systems, Nordion, Inc., IsoRay, Inc., Hitachi Medical Corporation, ViewRay, Inc., and other predominate & niche players.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports